852 related articles for article (PubMed ID: 23721855)
1. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
[TBL] [Abstract][Full Text] [Related]
2. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications.
Bansal S; Chawla D; Siddarth M; Banerjee BD; Madhu SV; Tripathi AK
Clin Biochem; 2013 Jan; 46(1-2):109-14. PubMed ID: 23103709
[TBL] [Abstract][Full Text] [Related]
3. Association of RAGE gene polymorphism with vascular complications in Indian type 2 diabetes mellitus patients.
Tripathi AK; Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP
Diabetes Res Clin Pract; 2014 Mar; 103(3):474-81. PubMed ID: 24418399
[TBL] [Abstract][Full Text] [Related]
4. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.
Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP; Tripathi AK
Microvasc Res; 2014 Sep; 95():1-6. PubMed ID: 24984291
[TBL] [Abstract][Full Text] [Related]
5. Association between the RAGE gene -374T/A, -429T/C polymorphisms and diabetic nephropathy: a meta-analysis.
Shi Z; Lu W; Xie G
Ren Fail; 2015 Jun; 37(5):751-6. PubMed ID: 25707513
[TBL] [Abstract][Full Text] [Related]
6. The Association of -429T>C and -374T>A Polymorphisms in the RAGE Gene with Polycystic Ovary Syndrome.
Park JH; Li L; Choi JW; Baek KH
Int J Med Sci; 2016; 13(6):451-6. PubMed ID: 27279795
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
8. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Xu J; Liao YF; Zhou WP; Ming HL; Wang QH
Genet Test Mol Biomarkers; 2015 Aug; 19(8):411-7. PubMed ID: 26083329
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the receptor for advanced glycation end products as vasculopathy predictor in sickle cell disease.
Safwat NA; ELkhamisy MM; Abdel-Wahab SEA; Hamza MT; Boshnak NH; Kenny MA
Pediatr Res; 2021 Jan; 89(1):185-190. PubMed ID: 32544923
[TBL] [Abstract][Full Text] [Related]
10. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.
Peng WH; Lu L; Wang LJ; Yan XX; Chen QJ; Zhang Q; Zhang RY; Shen WF
Arch Med Res; 2009 Jul; 40(5):393-8. PubMed ID: 19766904
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.
Flekac M; Skrha J; Žídková K; Lacinová Z; Hilgertová J
Physiol Res; 2008; 57(5):717-726. PubMed ID: 17949258
[TBL] [Abstract][Full Text] [Related]
12. RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.
Wang P; Huang R; Lu S; Xia W; Cai R; Sun H; Wang S
PLoS One; 2016; 11(1):e0145521. PubMed ID: 26745632
[TBL] [Abstract][Full Text] [Related]
13. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease.
Kucukhuseyin O; Aydogan HY; Isbir CS; Isbir T
In Vivo; 2009; 23(6):949-54. PubMed ID: 20023238
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.
Chocholatý M; Jáchymová M; Schmidt M; Havlová K; Křepelová A; Zima T; Babjuk M; Kalousová M
Tumour Biol; 2015 Mar; 36(3):2121-6. PubMed ID: 25407489
[TBL] [Abstract][Full Text] [Related]
15. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes.
Kirbis J; Milutinović A; Steblovnik K; Teran N; Terzić R; Zorc M
Coll Antropol; 2004 Dec; 28(2):611-6. PubMed ID: 15666591
[TBL] [Abstract][Full Text] [Related]
16. Association of the receptor for advanced glycation end products gene polymorphisms with diabetic retinopathy in type 2 diabetes: a meta-analysis.
Yuan D; Yuan D; Liu Q
Ophthalmologica; 2012; 227(4):223-32. PubMed ID: 22354095
[TBL] [Abstract][Full Text] [Related]
17. The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients.
Picheth G; Costantini CO; Pedrosa FO; Leme da Rocha Martinez T; Maltempi de Souza E
Clin Chem Lab Med; 2007; 45(10):1268-72. PubMed ID: 17924846
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of -429T/C receptor for advanced glycation end products (RAGE) gene polymorphism with type 2 diabetic retinopathy and serum soluble RAGE levels in Pakistani patients.
Qayyum S; Afzal M; Naveed AK
J Pak Med Assoc; 2021 Apr; 71(4):1175-1180. PubMed ID: 34125766
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy.
Ng ZX; Kuppusamy UR; Tajunisah I; Fong KC; Chua KH
Diabetes Res Clin Pract; 2012 Mar; 95(3):372-7. PubMed ID: 22154374
[TBL] [Abstract][Full Text] [Related]
20. Association between the RAGE (receptor for advanced glycation end-products) -374T/A gene polymorphism and diabetic retinopathy in T2DM.
Tao D; Mai X; Zhang T; Mei Y
Rev Assoc Med Bras (1992); 2017 Nov; 63(11):971-977. PubMed ID: 29451661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
